EMMA STEPHENS: Open Payments
NPI 1548852593 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$521 in 20 payments from 10 companies in 2025. Trend: 2023 $754 · 2024 $806 · 2025 $521
Food & beverage: $521
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 4 | $174 |
| Novartis Pharmaceuticals Corporation | 3 | $73 |
| ABBVIE INC. | 3 | $51 |
| ConvaTec Inc. | 2 | $45 |
| Janssen Biotech, Inc. | 2 | $41 |
| UCB, Inc. | 1 | $37 |
| Organogenesis Inc. | 1 | $31 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $26 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| Amgen Inc. | 1 | $21 |
Products named: DUPIXENT, INNOVAMATRIX AC, TREMFYA, Bimzelx, RINVOQ, NUSHIELD, Rhapsido, OTEZLA.
Industry payments across AL — which companies pay providers there.
